UMIN ID: UMIN000032637
Registered date:01/06/2018
Prospective study for effectiveness of Etelcalcetide hydrochloride (Parsabiv) on patients treated with hemodialysis
Basic Information
Recruitment status | Pending |
---|---|
Health condition(s) or Problem(s) studied | patients treated with hemodialysis |
Date of first enrollment | 2018/06/01 |
Target sample size | 200 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | Change of QOL (every month) |
---|---|
Secondary Outcome | Estimation od complication (every month) CTR/ECG (every month) bone mineral density and UCG(1 year later) General blood test (every month) Check of leftover medicine |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 80years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | Patients decided as incompetent for this study by the doctor Patietns showing contraindication for PARSABIV Patients showing low Ca(<8.4) before admonistration of PARSABIV Patients having malignant diseases Patients having serious diseases in liver, kidney (other than CRF), and heart. Patients treated with cinacalcet or bisphosphonate |
Related Information
Primary Sponsor | Zenjinkai Shinyokohama Daiichi Clinic Division of Nephrology |
---|---|
Secondary Sponsor | Yokohama Daiichi Hospital |
Source(s) of Monetary Support | Zenjinkai Shinyokohama Daiichi Clinic Division of Nephrology |
Secondary ID(s) |
Contact
public contact | |
Name | Ashio Yoshimura |
Address | ShinyokohamaChitosekannkoBLG 8F,3-6-4 Shinyokohama,kouhoku-ku,Yokohama Japan 222-0033 |
Telephone | 045-477-3412 |
shinyokohd@gmail.com | |
Affiliation | Zenjinkai Shinyokohama Daiichi Clinic Division of Nephrology |
scientific contact | |
Name | Ashio Yoshimura |
Address | ShinyokohamaChitosekannkoBLG 8F,3-6-4 Shinyokohama,kouhoku-ku,Yokohama Japan |
Telephone | 045-477-3412 |
shinyokohd@gmail.com | |
Affiliation | Zenjinkai Shinyokohama Daiichi Clinic Division of Nephrology |